|
1.
|
Glick AB. The Role of TGFß Signaling in Squamous Cell Cancer: Lessons from Mouse Models. J Skin Cancer. 2012; 2012:249063.
|
|
|
|
|
2.
|
Gunderson AJ, Mohammed J, Horvath FJ, Podolsky MA, Anderson CR, Glick AB. CD8(+) T Cells Mediate RAS-Induced Psoriasis-Like Skin Inflammation through IFN-?. J Invest Dermatol. 2013 Apr; 133(4):955-63.
|
|
|
|
|
3.
|
Plichta KA, Mathers JL, Gestl SA, Glick AB, Gunther EJ. Basal but not Luminal Mammary Epithelial Cells Require PI3K/mTOR Signaling for Ras-Driven Overgrowth. Cancer Res. 2012 Nov 15; 72(22):5856-66.
|
|
|
|
|
4.
|
Mohammed J, Gunderson AJ, Khong HH, Koubek RD, Udey MC, Glick AB. TGFß1 Overexpression by Keratinocytes Alters Skin Dendritic Cell Homeostasis and Enhances Contact Hypersensitivity. J Invest Dermatol. 2013 Jan; 133(1):135-43.
|
|
|
|
|
5.
|
Shi C, Cooper TK, McCloskey DE, Glick AB, Shantz LM, Feith DJ. S-adenosylmethionine decarboxylase overexpression inhibits mouse skin tumor promotion. Carcinogenesis. 2012 Jul; 33(7):1310-8.
|
|
|
|
|
6.
|
Zhu B, Khozoie C, Bility MT, Ferry CH, Blazanin N, Glick AB, Gonzalez FJ, Peters JM. Peroxisome proliferator-activated receptor ß/d cross talks with E2F and attenuates mitosis in HRAS-expressing cells. Mol Cell Biol. 2012 Jun; 32(11):2065-82.
|
|
|
|
|
7.
|
Glick A. A new xenotransplantation model reveals tumor-initiating cells in cutaneous squamous cell carcinoma. J Invest Dermatol. 2012 Feb; 132(2):261-2.
|
|
|
|
|
8.
|
Markell LM, Masiuk KE, Blazanin N, Glick AB. Pharmacologic inhibition of ALK5 causes selective induction of terminal differentiation in mouse keratinocytes expressing oncogenic HRAS. Mol Cancer Res. 2011 Jun; 9(6):746-56.
|
|
|
|
|
9.
|
Mordasky Markell L, Pérez-Lorenzo R, Masiuk KE, Kennett MJ, Glick AB. Use of a TGFbeta type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFbeta signaling in tumor promotion and progression. Carcinogenesis. 2010 Dec; 31(12):2127-35.
|
|
|
|
|
10.
|
Koesters R, Kaissling B, Lehir M, Picard N, Theilig F, Gebhardt R, Glick AB, Hähnel B, Hosser H, Gröne HJ, Kriz W. Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol. 2010 Aug; 177(2):632-43.
|
|
|
|
|
11.
|
Mohammed J, Ryscavage A, Perez-Lorenzo R, Gunderson AJ, Blazanin N, Glick AB. TGFbeta1-induced inflammation in premalignant epidermal squamous lesions requires IL-17. J Invest Dermatol. 2010 Sep; 130(9):2295-303.
|
|
|
|
|
12.
|
Pérez-Lorenzo R, Markell LM, Hogan KA, Yuspa SH, Glick AB. Transforming growth factor beta1 enhances tumor promotion in mouse skin carcinogenesis. Carcinogenesis. 2010 Jun; 31(6):1116-23.
|
|
|
|
|
13.
|
Ponnamperuma RM, King KE, Elsir T, Glick AB, Wahl GM, Nister M, Weinberg WC. The transcriptional regulatory function of p53 is essential for suppression of mouse skin carcinogenesis and can be dissociated from effects on TGF-beta-mediated growth regulation. J Pathol. 2009 Oct; 219(2):263-74.
|
|
|
|
|
14.
|
Jabbar SF, Abrams L, Glick A, Lambert PF. Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene. Cancer Res. 2009 May 15; 69(10):4407-14.
|
|
|
|
|
15.
|
Bae DS, Blazanin N, Licata M, Lee J, Glick AB. Tumor suppressor and oncogene actions of TGFbeta1 occur early in skin carcinogenesis and are mediated by Smad3. Mol Carcinog. 2009 May; 48(5):441-53.
|
|
|
|
|
16.
|
Zheng T, Oh MH, Oh SY, Schroeder JT, Glick AB, Zhu Z. Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. J Invest Dermatol. 2009 Mar; 129(3):742-51.
|
|
|
|
|
17.
|
Bility MT, Devlin-Durante MK, Blazanin N, Glick AB, Ward JM, Kang BH, Kennett MJ, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis. Carcinogenesis. 2008 Dec; 29(12):2406-14.
|
|
|
|
|
18.
|
Shukla A, Ho Y, Liu X, Ryscavage A, Glick AB. Cripto-1 alters keratinocyte differentiation via blockade of transforming growth factor-beta1 signaling: role in skin carcinogenesis. Mol Cancer Res. 2008 Mar; 6(3):509-16.
|
|
|
|
|
19.
|
Glick AB, Perez-Lorenzo R, Mohammed J. Context-dependent regulation of cutaneous immunological responses by TGFbeta1 and its role in skin carcinogenesis. Carcinogenesis. 2008 Jan; 29(1):9-14.
|
|
|
|
|
20.
|
Glick A, Ryscavage A, Perez-Lorenzo R, Hennings H, Yuspa S, Darwiche N. The high-risk benign tumor: evidence from the two-stage skin cancer model and relevance for human cancer. Mol Carcinog. 2007 Aug; 46(8):605-10.
|
|
|
|
|
21.
|
Garcia RJ, Ittah A, Mirabal S, Figueroa J, Lopez L, Glick AB, Kos L. Endothelin 3 induces skin pigmentation in a keratin-driven inducible mouse model. J Invest Dermatol. 2008 Jan; 128(1):131-42.
|
|
|
|
|
22.
|
Darwiche N, Ryscavage A, Perez-Lorenzo R, Wright L, Bae DS, Hennings H, Yuspa SH, Glick AB. Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion. Oncogene. 2007 Oct 18; 26(48):6885-95.
|
|
|
|
|
23.
|
Kirshner J, Jobling MF, Pajares MJ, Ravani SA, Glick AB, Lavin MJ, Koslov S, Shiloh Y, Barcellos-Hoff MH. Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress. Cancer Res. 2006 Nov 15; 66(22):10861-9.
|
|
|
|
|
24.
|
Gerdes MJ, Myakishev M, Frost NA, Rishi V, Moitra J, Acharya A, Levy MR, Park SW, Glick A, Yuspa SH, Vinson C. Activator protein-1 activity regulates epithelial tumor cell identity. Cancer Res. 2006 Aug 1; 66(15):7578-88.
|
|
|
|
|
25.
|
Glick AB, Yuspa SH. Tissue homeostasis and the control of the neoplastic phenotype in epithelial cancers. Semin Cancer Biol. 2005 Apr; 15(2):75-83.
|
|
|
|
|
26.
|
Suh KS, Mutoh M, Gerdes M, Crutchley JM, Mutoh T, Edwards LE, Dumont RA, Sodha P, Cheng C, Glick A, Yuspa SH. Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor {alpha}-induced apoptosis, and inhibits tumor growth. Cancer Res. 2005 Jan 15; 65(2):562-71.
|
|
|
|
|
27.
|
Woodworth CD, Michael E, Smith L, Vijayachandra K, Glick A, Hennings H, Yuspa SH. Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte. Carcinogenesis. 2004 Sep; 25(9):1771-8.
|
|
|
|
|
28.
|
Glick AB. TGFbeta1, back to the future: revisiting its role as a transforming growth factor. Cancer Biol Ther. 2004 Mar; 3(3):276-83.
|
|
|
|
|
29.
|
Liu X, Lee J, Cooley M, Bhogte E, Hartley S, Glick A. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma. Cancer Res. 2003 Nov 15; 63(22):7760-8.
|
|
|
|
|
30.
|
Vijayachandra K, Lee J, Glick AB. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model. Cancer Res. 2003 Jul 1; 63(13):3447-52.
|
|
|
|
|
31.
|
Diamond I, Owolabi T, Marco M, Lam C, Glick A. Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. J Invest Dermatol. 2000 Nov; 115(5):788-94.
|
|
|
|
|
32.
|
Glick AB, Weinberg WC, Wu IH, Quan W, Yuspa SH. Transforming growth factor beta 1 suppresses genomic instability independent of a G1 arrest, p53, and Rb. Cancer Res. 1996 Aug 15; 56(16):3645-50.
|
|
|
|
|
33.
|
Darwiche N, Celli G, Tennenbaum T, Glick AB, Yuspa SH, De Luca LM. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors. Cancer Res. 1995 Jul 1; 55(13):2774-82.
|
|
|
|
|
34.
|
Yuspa SH, Dlugosz AA, Cheng CK, Denning MF, Tennenbaum T, Glick AB, Weinberg WC. Role of oncogenes and tumor suppressor genes in multistage carcinogenesis. J Invest Dermatol. 1994 Nov; 103(5 Suppl):90S-95S.
|
|
|
|
|
35.
|
Hennings H, Glick AB, Lowry DT, Krsmanovic LS, Sly LM, Yuspa SH. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis. 1993 Nov; 14(11):2353-8.
|
|
|
|
|
36.
|
Glick AB, Kulkarni AB, Tennenbaum T, Hennings H, Flanders KC, O'Reilly M, Sporn MB, Karlsson S, Yuspa SH. Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc Natl Acad Sci U S A. 1993 Jul 1; 90(13):6076-80.
|
|
|
|
|
37.
|
Fisher GJ, Tavakkol A, Griffiths CE, Elder JT, Zhang QY, Finkel L, Danielpour D, Glick AB, Higley H, Ellingsworth L, et al. Differential modulation of transforming growth factor-beta 1 expression and mucin deposition by retinoic acid and sodium lauryl sulfate in human skin. J Invest Dermatol. 1992 Jan; 98(1):102-8.
|
|
|
|